Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers

Conditions:   Breast Cancer;   HER2-positive Breast Cancer;   ER Positive Breast Cancer;   PR-Positive Breast Cancer Interventions:   Drug: Neratinib;   Drug: Letrozole (L) or Anastrozole (A);   Drug: Trastuzumab Sponsors:   Ruth O'Regan;   Puma Biotechnology, Inc.;   University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials